Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
about
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsMycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsMycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantationGlucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsMycophenolate mofetil versus methotrexate for prevention of acute graft-versus-host disease in patients receiving allogeneic hematopoietic stem cell transplantationMetabolic consequences of modern immunosuppressive agents in solid organ transplantationMycophenolate fetal toxicity and risk evaluation and mitigation strategiesMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionmTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathwayRisk evaluation and mitigation strategy programs in solid organ transplantation: the promises of information technologyComparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programmeEfficacy and safety of treatment of hepatitis C virus infection in renal transplant recipientsImmunosuppression in kidney transplantation.Delayed Graft Function in Kidney Transplants: Time Evolution, Role of Acute Rejection, Risk Factors, and Impact on Patient and Graft Outcome.West Meets East.A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation.Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis.Risk of bladder cancer in renal transplant recipients: a meta-analysis.Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA.Current status of immunosuppressive agents for solid organ transplantation in children.Genes and beans: pharmacogenomics of renal transplant.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Mycophenolate revisited.Clinical experience with induction therapy in renal transplantation.Ischaemic and inflammatory injury in renal graft from brain death donation: an update review.Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.The correlation between renal transplantation and liver carcinoma: a meta-analysis.Enteric-coated mycophenolate sodium.Patient and graft outcome in current era of immunosuppression: a single centre pilot study.Nanotechnological Approaches to Immunosuppression and Tolerance Induction.Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.
P2860
Q24187112-FA223A7F-252B-4859-9CA9-88E113AB13EDQ24187213-36AFE0A6-CC46-4C2A-B5B4-25F7C8E4F7CCQ24194807-848EE209-C6FE-4545-A1F6-29BA3F206F22Q24194975-3215743C-17DC-43F8-9FDA-8A9411C0971CQ24202699-E6FF8AC1-E09D-452E-8F9F-1F92AA19BBB1Q26746936-716A7DE8-158F-4818-8E66-D51C3436CFFAQ26822840-E91BA92C-D105-4143-A820-1C973E51A82BQ28080720-ADB5642C-60F5-4AC0-8842-4842911B766BQ33424013-524A5F68-FA6D-4AB7-8833-7A97C09AA94DQ33944794-A800E6DF-0142-419F-B370-90CEDEC99523Q34077012-967DE393-C5CE-4793-8361-844D87883FF9Q34235791-CAE51E68-65C7-4662-BFBF-006D4716F9F4Q35351287-5164E5DA-B7E1-459A-A6D4-77447B2A4348Q35653600-8846E587-31D9-4A11-ADFD-5DF4E8666DE6Q35714310-459D8B85-3195-4C95-B7D3-22CB8D33DCD8Q36089298-6814006A-68CF-40FB-8857-46377BD4A850Q37069890-F7A8B788-B329-4CEE-BF7B-237522632159Q37246506-32187DCF-0168-4483-B3C8-78AD47F92400Q37280007-21E97198-1E3B-4134-92D0-7F4E4DA3D6EDQ37681727-9CD4B767-3494-4F43-A038-B97D66E468A6Q37810962-61836ABF-2FF0-4DD1-BD25-C04F0B18B3B3Q37987565-FC905407-EBD0-4824-A397-1701E2D2717FQ38104742-BAE9850A-50F1-4293-ADBD-841C4CBB1BA6Q38208983-5D237C4A-46C1-4AFE-AD8D-CDDAB4A3190EQ38373106-0B6E3053-C368-4DAE-AC9B-89238A768F05Q38623201-56CAA787-765B-4DDC-9C88-31389956032BQ38690664-625E6BE6-2C1F-4BC7-88CC-AEDF6BD35D91Q38967258-B809C1F7-4924-4427-916D-9F39369118B1Q39016704-C5ECE97B-668B-4BFC-8528-E1AE68E0623EQ41001229-B4A310F2-4560-40D8-882A-5E60EFA453D5Q41924348-B4DC2B27-FF5E-4E27-A887-9EFEB627ED86Q42925114-15BEFE52-A193-4C31-A5A7-5ADE989D2262Q45354755-81E82F0D-F38C-4C7C-8C55-F7C86156182FQ50066247-DA869C3F-0BAF-4172-BB72-97507448EDB0Q52845695-494A326E-913E-46AA-9D5F-08A75B68084EQ55266341-916D3EA1-E370-46D6-913F-B8005C4508C5Q55382907-4F0AC3C1-13AE-486E-83E9-A57464AEA442
P2860
Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@ast
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@en
type
label
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@ast
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@en
prefLabel
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@ast
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@en
P2093
P1433
P1476
Mycophenolate mofetil decrease ...... hioprine: a systematic review.
@en
P2093
Leticia Barcena
Neil K Russell
Peter J Morris
P304
P356
10.1097/TP.0B013E3181952623
P577
2009-03-01T00:00:00Z